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ABSTRACT 
 
C-reactive protein (CRP) is an acute phase reactant the concentration of 
which increases significantly following tissue injury or inflammation. It is 
present in the albumin fraction of the serum of patients and is antigenic upon 
injection into rabbits. We report here the development of a local latex reagent 
coated with rabbit anti-CRP. For this purpose CRP was isolated from pooled 
sera of patients and injected into rabbits. CRP rabbit antiserum was purified by 
using ammonium sulfate precipitation. Followed by passing on ion exchange 
chromatography (Diethylaminoethyl "DEAE" cellulose). Then, latex particles 
were coated with purified antisera.  The prepared CRP latex reagent 
agglutination was observed upon the addition of patients' sera and compared 
with that of normal sera. In addition, it was evaluated against a standard CRP 
latex reagent. The prepared reagent gave positive results (100%) with patients' 
sera and the positive control of the standard kit. While, the negative control of 
the standard kit and 30% of the normal sera gave negative results. 
____________________________________________________________________ 
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  الإنسان المنفعل من مصل Cتحضير محلول لاتكس لبروتين 
  
  ـار منـــى صبـ                   ليلى خالد مهدي      ر عبد الوهاب الشالجي سح    
  /ـةقسـم التحليلات المرضي           /ةقسم الأحياء المجهري         / ةحيائيسم التقنيات الاق     
  / ة التقنية الطبيةـالكلي               /كلية طب النهرين                   /لومـة العـكلي       
  ـيالتقنــــهيئة التعليم                  راقـالع                   جامعة بغداد         
  
  
  
  5002/6/21 قبل بتاريخ             5002/2/51استلم بتاريخ 
  
  ةـالخلاص
  
 احد بروتينات الطور الحاد الذي يزداد تركيزه بشكل ملحوظ بعـد اصـابة Cيعد البروتين المنفعل       
يوجد هذا البروتين في جزء الالبومين من مصل المرضى وذو فعالية مستضدية عنـد . النسيج والالتهاب 
 Cتم في  هذا البحث تطوير  محلول لاتكس محلي مغلف بالاضداد النوعيـة لبـروتين . حقنة في الارنب 
 من خليط امصال مرضـى و تـم Cالمنفعل المحضر في الارنب ولهذا الغرض تم عزل البروتين المنفعل 
ي الارنـب  المحـضرة ف  ـCو من ثم تمت تنقية  الاضداد النوعية  للبروتين المنفعـل , حقنة في الارنب 
 بعد ذلك تم تغليف محلول الاتكـس EAED,باستخدام الترسيب بكبريتات الامونيوم ثم بالمبادل اللايوني 
لوحظ حدوث التلازن مع محلول الاتكس المحضر بعد اضافة مصل المرضى لـه . بالاضداد النوعية النقبة 
اذ اعطـى , ل لاتكـس قياسـي قييست بعد ذلك العدة المحضرة مع محلو .  بالمقارنة مع المصل الطبيعي 
المحلول المحضر محليا تفاعلا ايجابيا مع امصال المرضى والسيطرة الايجابية للعـدة القياسـية بنـسبة 
وكذلك مع السيطرة السالبة للعـدة  %  03بينما اعطت تفاعلا سلبيا مع امصال المرضى بنسبة %  001
 .القياسية
 
 
 
 
 
 
 
 
 
 
 
 
moc.yrotcaffdp.www noisrev lairt orP yrotcaFfdp htiw detaerc FDP
Iraqi J. Biotech.,Vol.5 , No.1:112-122, 2006 
 114
INTRODUCTION 
 
Since the discovery of CRP by Tillet and Francis in 1930 (1), this acute phase 
serum protein has been used as a marker of infection, inflammation and tissue 
necroses. It has been established that CRP is synthesized by liver cells (2).  
Several in vitro studies have indicated that CRP may play an important role in 
modifying inflammatory and immune responses (3). CRP in complex with an 
appropriate ligand can activate the classical complement pathway (4). It has also 
been shown to enhance phagocytosis (5), bind to certain subpopulations of T-cells 
interfering with some of their functions (6), and inhibit platelet aggregation and 
mediator release (7).  
Studies have emphasized the clinical value of CRP quantitation in a wide 
variety of diseases including systemic lupus erythematosus (8), rheumatoid arthritis 
(9), myocardial infarction (10), and pneumonitis (11). The CRP level, when 
compared to other acute phase parameters, is useful in the management of infection, 
especially recommended in neonatal sepsis and meningitis (12, 13). It is an effective 
diagnostic and disease monitoring tool, thus rapid and reliable quantitative assays for 
CRP are essential. Furthermore, reliable estimates of moderate levels of CRP are 
needed to help differentiate between viral and bacterial infections as well as for the 
evaluation of therapeutic effectiveness (12). 
Because of their rapidly and ease of performance, semiquantitative CRP latex 
slide agglutination tests are increasing in availability and popularity. The present 
paper describes the preparation of CRP latex reagent. 
 
MATERIALS & METHODS 
Isolation of CRP 
 CRP was isolated from pooled sera (15 ml) having a CRP titer of 1:4, 
obtained from patients with acute infections as described by Macleod and Avery (14) 
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with some modifications. These sera were brought to 33% saturation with 
ammonium sulfate, centrifuged and the supernatant raised to 50% saturation with the 
same salt, centrifuged and the supernatant was brought to 75% then 100% saturation, 
respectively. The precipitate (after 75% saturation), recovered by centrifugation was 
dialyzed against three litters of 0.01% CaCl2 in physiological saline. Protein 
concentration was determined by spectrophotometer (Schimadzu-Japan) at 280 nm; 
while the presence of CRP was determined by adding a constant amount of a 
standard CRP latex reagent to serial dilutions of the isolated protein. The preparation 
of protein was stored at 4؛C and used as immunizing antigen. 
 
Production of anti-CRP antibodies 
Rabbits were immunized by seven intravenous injections on each of seven 
consecutive days with 1ml of the prepared antigen containing 1mg/ml of protein. 
After a week two booster doses were given, the interval between injections was one 
week. Sera were collected seven days after the last injection and preserved by 
freezing at -20 ؛C (14, 15). Skin test was performed in order to check the 
sensitization of the rabbits to the injected antigen, by injecting 0.1ml (1mg/ml) of the 
isolated protein subcutaneously. The second day a positive reaction was determined 
by the appearance of erythema and edema at the site of injection (1). 
 
Purification of CRP antibodies 
This was achieved by precipitation with ammonium sulfate (33%). Then 
samples were collected and dialyzed against phosphate buffer pH 8.0. The protein 
concentration was measured by spectrophotometer. The sample which was 
precipitated by ammonium sulfate was applied on DEAE cellulose column. Fractions 
were measured by spectrophotometer. The fractions that showed the highest 
absorbance (peak) were collected and dialyzed against 1500 ml of distilled water at 
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4؛C. The volume was concentrated and the concentration of protein was determined 
by spectrophotometer (17). 
 
Coating latex particles with purified CRP antibodies   
Latex particles (0.8 µ, Difco-USA) were sensitized by adding equal volumes of 
CRP antibodies (concentration 3 mg/ml) to a 10% v/v suspension of latex particles 
and rotating for one hour. The suspension was left at 4؛C overnight, before 
centrifugation at 13000 rpm. Then the supernatant was discarded and the pellet 
resuspended to 5% concentration in phosphate buffer, pH 8.0 and mixed by vortex 
(18). Then 0.1% of bovine serum albumin was added to block any remaining latex 
protein binding sites (17). Later on, sensitized latex solution was stored at 4؛C.  
Latex agglutination test was performed by adding 20 µl of serum with a drop 
of the prepared CRP latex reagent on a microscopical slide with rotation for up to 
two minutes. Positive result was determined by forming visible agglutination. 
 
Evaluation of latex reagent 
The prepared CRP latex reagent was evaluated by using 12 serum samples of 
patients in comparison with standard CRP kit (Omega Diagnostics Limited- UK). In 
addition 10 normal serum samples and positive and negative controls of the standard 
kit were also tested with the prepared latex reagent. 
 
RESULTS & DISCUSSION 
 
The most rapid simple method available for CRP determination is the slide 
agglutination test. The CRP used for the immunization of rabbits was prepared from 
blood obtained from cases with acute infections. It was found that CRP is combined 
with lipid in the blood and lipid-protein complex precipitate in the presence of 
calcium ion if the salt concentration is low (19). Thus the precipitate that formed 
after saturation with ammonium sulfate can be dialyzed with a diluted solution of 
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calcium chloride without loss of the reactive protein. This method was suitable for 
obtaining the C-protein relatively free from the normal serum proteins and in a form 
suitable for testing its antigenicity in rabbits. 
Saturation with ammonium sulfate was applied for the isolation of CRP (Table 
1). This resulted in a purification factor of 6.3 and a recovery of 66.7 %. The CRP 
content so prepared was 0.048 mg/ml. 
The results of the CRP content demonstrated that the reactive protein isolated 
by ammonium sulfate is antigenic and in this form is capable of inciting in rabbits the 
production of antibodies specifically reactive with the homologous protein in the 
native state in which it exists in the serum of infected patients. 
The CRP antiserum was firstly purified by ammonium sulfate. The 
concentration of protein was 32.2 mg/ml. Ammonium sulfate precipitation is the 
most widely used technique for the preparation of a crude immunoglobulin fraction 
from whole serum. It is often useful as a first step in isolation as many unwanted 
serum proteins, for example albumin, will remain in solution when immunoglobulins 
are precipitated. Ammonium sulfate is important for concentrating immunoglobulins 
from dilute solution (17). 
The precipitated sample was applied on DEAE-cellulose column. The results 
showed one peak (Figure 1). The concentration of CRP-antibodies purified by 
DEAE-cellulose was 0.73 mg/ml. Ion exchange chromatography is one of the most 
popular methods for the separation of serum proteins and the isolation of 
immunoglobulins. For preparing IgG alone, the DEAE-cellulose is equilibrated under 
conditions of pH and ionic strength which allow all the serum proteins to bind except 
IgG (17). 
The results showed that the presence of CRP could be detected in patients' sera 
when the latter was diluted 1 part in 4, when the prepared CRP latex reagent was 
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used. The prepared reagent gave positive results (100%) with patients' sera and the 
positive control of the standard kit. Although, the results of the prepared latex gave 
concordance results as with the standard kit, false positive agglutination was also 
detected with  normal sera (30%), when  were used.  
The ambiguous agglutination for false positive finding with the prepared CRP 
latex reagent might be due to heterogeneity of CRP. It was described that anti-human 
CRP produced in rabbits could contain two subpopulations of specific antibodies 
(20). Thus, differing proportions of unlike antibody subpopulations coating the latex 
particles might well give varying agglutination patterns. It is recommended to 
produce the anti-CRP antibodies from other animal species, such as sheep or goat. 
The observed differences in results between the standard and prepared CRP 
latex reagents might depend on the amount and properties, such as avidity or 
specificity, of the coating antibodies. The agglutination and / or prozoning produce 
by one sort of antibody may be masked by another type (21). 
Furthermore, other explanation of the false positive results, is that rheumatoid 
factor (RF) can interfere with the detection of CRP by latex agglutination, causing 
false positive results, especially when RF is present in high titers. This was expected 
since RF reacts with the IgG anti-CRP used to sensitize the latex particles. In 
addition, another observation, using radioimmunoassay for IgM RF, indicate that 
rabbit IgG serves more sensitively as the antigen than either horse, sheep or goat IgG 
(22). 
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Table 1: Measurement of C-reactive protein (CRP) from human serum 
 
 
 
Saturation 
with 
Ammonium 
Sulfate 
 
Volume 
ml 
 
Protein 
conc. 
mg/ml 
CRP 
content* 
(activity 
mg/ml) 
Total 
activity 
mg 
Specific 
activity 
Recovery 
% 
Purification 
factor 
Crude 15 86.2 0.024 0.36 0.00027 100 1 
33 % 5 39.4 0.006 0.03 0.00015 8.33 5.6 
50 % 5 20 0.012 0.06 0.0006 16.66 2.2 
75 % 5 28.2 0.048 0.24 0.0017 66.66 6.3 
100 % 5 0.521 0 0 0 0 0 
         
       *CRP was determined by CRP agglutination kit. 
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Figure 1: Elution profile of C-reactive protein antibodies from DEAE- cellulose column 
of bed volume 25 x 2.5 cm, flow rate 25 ml/hour, column 25 x 2.5 cm, 3ml/tube and the 
antibodies were eluted with 0.5M phosphate buffer pH 8. 
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